Paradise Renal Denervation System
Payments companies reported to CMS as associated with Paradise Renal Denervation System. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Paradise Renal Denervation System, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Paradise Renal Denervation System
These are the largest totals companies reported as associated with Paradise Renal Denervation System. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Taisei Kobayashi | Philadelphia, PA | Interventional Cardiology | $9,288.27 |
| Wayne Batchelor | Falls Church, VA | Interventional Cardiology | $8,923.93 |
| Thomas Todoran | Pawleys Island, SC | Interventional Cardiology | $8,181.15 |
| Michael Bloch | Reno, NV | Internal Medicine | $7,226.86 |
| Luke Laffin | Chicago, IL | Internal Medicine | $7,101.12 |
| Tiffany Randolph | Greensboro, NC | Cardiovascular Disease | $6,809.26 |
| Aravinda Nanjundappa | Beckley, WV | Interventional Cardiology | $4,428.73 |
| Debbie Cohen Stein | Philadelphia, PA | Nephrology (Internal Medicine) | $4,319.79 |
| Wissam Gharib | Morgantown, WV | Interventional Cardiology | $4,142.14 |
| Florian Rader | West Hollywood, CA | Cardiovascular Disease | $3,785.47 |
Prescribed Paradise Renal Denervation System?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.